Skip Nav Destination
Article navigation
Education|
February 1985
Does Hyperkalemia Contraindicate the Use of Bupivacaine or the Use of Succinylcholine to Treat Bupivacaine-induced Toxicity in Humans?
DANIEL C. MOORE, M.D.
;
DANIEL C. MOORE, M.D.
*Professor, Department of Anesthesiology, University of Washington, School of Medicine, Seattle, Washington 98195.
Search for other works by this author on:
L. DONALD BRIDENBAUGH, M.D.
L. DONALD BRIDENBAUGH, M.D.
†Deputy Chief, Department of Anesthesiology, The Mason Clinic, Seattle, Washington 98111.
Search for other works by this author on:
Anesthesiology February 1985, Vol. 62, 195–197.
Citation
DANIEL C. MOORE, L. DONALD BRIDENBAUGH; Does Hyperkalemia Contraindicate the Use of Bupivacaine or the Use of Succinylcholine to Treat Bupivacaine-induced Toxicity in Humans?. Anesthesiology 1985; 62:195–197 doi: https://doi.org/10.1097/00000542-198502000-00023
Download citation file:
Citing articles via
Related Articles
Succinylcholine-induced Hyperkalemia in Acquired Pathologic States: Etiologic Factors and Molecular Mechanisms
Anesthesiology (January 2006)
Biopharmaceutics of a New Transdermal Fentanyl Device
Anesthesiology (September 1995)
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review
Anesthesiology (January 2019)
Prolonged d-Tubocurarine Infusion and/or Immobilization Cause Upregulation of Acetylcholine Receptors and Hyperkalemia to Succinylcholine in Rats
Anesthesiology (February 1996)
Succinylcholine and Intracranial Pressure
Anesthesiology (December 2018)
